Dimerix is discovering and developing important new drug therapies for major unmet medical needs identified using our proprietary cell-based drug discovery platform.
At the same time, our transformative drug discovery technology, known as Receptor-HIT, provides Dimerix with ongoing revenues from global industry partners seeking to improve their own programs.
Our vision is to positively improve human health through the creation of new treatments for major unmet medical needs.
To view the presentation from BIO CEO & Investor conference click here
Read our newsletter here.
Read about this here.
Read the release here.
Watch the interview on YouTube
To view our most recent presentation please click here
To read report please click here
Read the article here.
View stock price: ASX Stock Price